中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
42期
6747-6751
,共5页
叶锦霞%吴广文%李西海%郑春松%许惠凤%叶蕻芝%刘献祥
葉錦霞%吳廣文%李西海%鄭春鬆%許惠鳳%葉蕻芝%劉獻祥
협금하%오엄문%리서해%정춘송%허혜봉%협홍지%류헌상
组织构建%软骨细胞%透骨消痛胶囊%中药%凋亡%Rac1蛋白%Cdc42蛋白%国家自然科学基金
組織構建%軟骨細胞%透骨消痛膠囊%中藥%凋亡%Rac1蛋白%Cdc42蛋白%國傢自然科學基金
조직구건%연골세포%투골소통효낭%중약%조망%Rac1단백%Cdc42단백%국가자연과학기금
chondrocytes%apoptosis%drugs,Chinese HERBAL%rac1 GTP-binding protein%cdc42 GTP-binding protein
背景:透骨消痛胶囊治疗早、中期骨性关节炎有较好疗效,但作用机制尚未完全阐明。小GTP酶Rho能够抑制软骨细胞肥大分化,促进软骨细胞的凋亡。<br> 目的:观察透骨消痛胶囊对体外培养凋亡大鼠关节软骨细胞Rac1和Cdc42的影响,并初步探讨其防治骨性关节炎的作用机制。<br> 方法:采用4周龄SD大鼠膝关节软骨建立稳定的软骨细胞体外培养体系,采用甲苯胺蓝染色法对第3代软骨细胞进行鉴定。用20μg/L的肿瘤坏死因子α诱导体外培养软骨细胞的凋亡,诱导成功后,给予透骨消痛胶囊(500,100,20 mg/L)孵育24 h后,分别用MTT法检测各组软骨细胞的存活率,用流式细胞仪检测各组软骨细胞的线粒体膜电位情况,Western Blot检测各组软骨细胞Rac1,Cdc42,Bcl-2及Bax蛋白表达。结果与结论:透骨消痛胶囊能够减少肿瘤坏死因子α所致的软骨细胞凋亡,提高线粒体膜电位,提高细胞的存活率,同时能够下调Rac1,Cdc42,Bax蛋白的表达,上调Bcl-2蛋白表达,差异均有显著性意义(P<0.05)。提示透骨消痛胶囊可能通过下调Rac1,Cdc42和 Bax蛋白表达,增加凋亡抑制基因Bcl-2蛋白表达,从而抑制软骨细胞的凋亡,而起到治疗骨性关节炎的疗效。
揹景:透骨消痛膠囊治療早、中期骨性關節炎有較好療效,但作用機製尚未完全闡明。小GTP酶Rho能夠抑製軟骨細胞肥大分化,促進軟骨細胞的凋亡。<br> 目的:觀察透骨消痛膠囊對體外培養凋亡大鼠關節軟骨細胞Rac1和Cdc42的影響,併初步探討其防治骨性關節炎的作用機製。<br> 方法:採用4週齡SD大鼠膝關節軟骨建立穩定的軟骨細胞體外培養體繫,採用甲苯胺藍染色法對第3代軟骨細胞進行鑒定。用20μg/L的腫瘤壞死因子α誘導體外培養軟骨細胞的凋亡,誘導成功後,給予透骨消痛膠囊(500,100,20 mg/L)孵育24 h後,分彆用MTT法檢測各組軟骨細胞的存活率,用流式細胞儀檢測各組軟骨細胞的線粒體膜電位情況,Western Blot檢測各組軟骨細胞Rac1,Cdc42,Bcl-2及Bax蛋白錶達。結果與結論:透骨消痛膠囊能夠減少腫瘤壞死因子α所緻的軟骨細胞凋亡,提高線粒體膜電位,提高細胞的存活率,同時能夠下調Rac1,Cdc42,Bax蛋白的錶達,上調Bcl-2蛋白錶達,差異均有顯著性意義(P<0.05)。提示透骨消痛膠囊可能通過下調Rac1,Cdc42和 Bax蛋白錶達,增加凋亡抑製基因Bcl-2蛋白錶達,從而抑製軟骨細胞的凋亡,而起到治療骨性關節炎的療效。
배경:투골소통효낭치료조、중기골성관절염유교호료효,단작용궤제상미완전천명。소GTP매Rho능구억제연골세포비대분화,촉진연골세포적조망。<br> 목적:관찰투골소통효낭대체외배양조망대서관절연골세포Rac1화Cdc42적영향,병초보탐토기방치골성관절염적작용궤제。<br> 방법:채용4주령SD대서슬관절연골건립은정적연골세포체외배양체계,채용갑분알람염색법대제3대연골세포진행감정。용20μg/L적종류배사인자α유도체외배양연골세포적조망,유도성공후,급여투골소통효낭(500,100,20 mg/L)부육24 h후,분별용MTT법검측각조연골세포적존활솔,용류식세포의검측각조연골세포적선립체막전위정황,Western Blot검측각조연골세포Rac1,Cdc42,Bcl-2급Bax단백표체。결과여결론:투골소통효낭능구감소종류배사인자α소치적연골세포조망,제고선립체막전위,제고세포적존활솔,동시능구하조Rac1,Cdc42,Bax단백적표체,상조Bcl-2단백표체,차이균유현저성의의(P<0.05)。제시투골소통효낭가능통과하조Rac1,Cdc42화 Bax단백표체,증가조망억제기인Bcl-2단백표체,종이억제연골세포적조망,이기도치료골성관절염적료효。
BACKGROUND:Tougu Xiaotong Capsule has pretty good clinical therapeutic effect on osteoarthritis of early and middle periods. However, the mechanism of Tougu Xiaotong Capsule is not ful y clarified. The RhoA GTPases can regulate chondrocyte apoptosis and hypertrophy. <br> OBJECTIVE:To observe the Tougu Xiaotong Capsule on the expression of Rac1and Cdc42 in tumor necrosis factor-α-induced in vitro cultured rat articular chondrocytes, and to explore its mechanism of action for combating osteoarthritis. <br> METHODS:Knee cartilage of the 4-week-old Sprague-Dawley rats was used to stably establish in vitro culture system of chondrocytes. Passage 3 chondrocytes were identified by toluidine blue staining. Chondrocyte apoptosis was successful y induced by 20μg/L tumor necrosis factor-αand then Tougu Xiaotong Capsule at different dosage (500, 100, 20 mg/L) was given after 24-hour incubation. MTT assay was used to detect cellsurvival, flow cytrometry to measure mitochondrial membrane potential, and western blot assay to determine the protein expression of Rac1, Cdc42, Bax and Bcl-2. <br> RESULTS AND CONCLUSION:Tougu Xiaotong Capsule could reduce tumor necrosis factor-α-induced apoptosis of chondrocytes to improve the survival rate of the cells, and at the same time, could down-regulate the protein expression of Rac1, Cdc42 and Bax and increase the protein expression of Bcl-2 significantly (P<0.05). Tougu Xiaotong Capsule possibly plays a therapeutic efficacy on osteoarthritis by reducing promote apoptosis Rac1, Cdc42 and Bax expression and increasing apoptosis inhibiting gene Bcl-2 expression, thereby to inhibit apoptosis of chondrocytes.